Candel Therapeutics Stock Filter Stocks by Fundamentals
| CADL Stock | USD 4.71 0.00 0.00% |
Candel Therapeutics fundamentals help investors to digest information that contributes to Candel Therapeutics' financial success or failures. It also enables traders to predict the movement of Candel Stock. The fundamental analysis module provides a way to measure Candel Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Candel Therapeutics stock.
Candel | Shares Owned by Institutions |
Candel Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Candel Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Candel Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Candel Therapeutics Institutional Holders
Institutional Holdings refers to the ownership stake in Candel Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Candel Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Candel Therapeutics' value.| Shares | Bank Of New York Mellon Corp | 2024-06-30 | 54.4 K | Bank Of America Corp | 2024-06-30 | 54.4 K | Charles Schwab Investment Management Inc | 2024-09-30 | 46.8 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 38.9 K | Advisor Group Holdings, Inc. | 2024-06-30 | 25.8 K | Rhumbline Advisers | 2024-06-30 | 23 K | Virtu Financial Llc | 2024-06-30 | 22.6 K | Vontobel Holding Ltd. | 2024-06-30 | 22 K | Jpmorgan Chase & Co | 2024-06-30 | 19.4 K | Northpond Ventures, Llc | 2024-09-30 | 1.9 M | Vanguard Group Inc | 2024-09-30 | 946.3 K |
Candel Fundamentals
| Return On Equity | -4.81 | ||||
| Return On Asset | -0.52 | ||||
| Current Valuation | 160.22 M | ||||
| Shares Outstanding | 32.48 M | ||||
| Shares Owned By Insiders | 30.39 % | ||||
| Shares Owned By Institutions | 22.53 % | ||||
| Number Of Shares Shorted | 2.1 M | ||||
| Price To Book | 30.41 X | ||||
| Price To Sales | 436.42 X | ||||
| Revenue | 31 K | ||||
| Gross Profit | (20.66 M) | ||||
| EBITDA | (37.43 M) | ||||
| Net Income | (37.94 M) | ||||
| Cash And Equivalents | 86.78 M | ||||
| Cash Per Share | 3.00 X | ||||
| Total Debt | 22.76 M | ||||
| Debt To Equity | 0.38 % | ||||
| Current Ratio | 14.86 X | ||||
| Book Value Per Share | 0.44 X | ||||
| Cash Flow From Operations | (34.24 M) | ||||
| Short Ratio | 7.72 X | ||||
| Earnings Per Share | (1.73) X | ||||
| Target Price | 11.0 | ||||
| Number Of Employees | 42 | ||||
| Beta | -0.87 | ||||
| Market Capitalization | 134.29 M | ||||
| Total Asset | 41.2 M | ||||
| Retained Earnings | (137.03 M) | ||||
| Working Capital | 22.61 M | ||||
| Net Asset | 41.2 M |
About Candel Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Candel Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Candel Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Candel Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Candel Therapeutics Piotroski F Score and Candel Therapeutics Altman Z Score analysis. For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.73) | Revenue Per Share 0.001 | Return On Assets (0.52) | Return On Equity (4.81) |
The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.